Lactose (India) Share Price

  • 155.250.10 (0.06%)
  • Volume: 3,928
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:43 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Lactose (India) Share P...

  • 155.250.10 (0.06%)
  • Volume: 3,928
Advertisment

Lactose (India) share price insights

View All

  • Company delivered ROE of 14.41% in year ending Mar 31, 2024 outperforming its 5 year avg. of 4.1%. (Source: Standalone Financials)

  • Company's annual revenue growth of 72.89% outperformed its 3 year CAGR of 47.7%. (Source: Standalone Financials)

  • Stock gave a 3 year return of 338.47% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

  • Company has spent 4.6% of its operating revenues towards interest expenses and 9.34% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Lactose (India) Ltd. share price moved up by 0.06% from its previous close of Rs 155.15. Lactose (India) Ltd. stock last traded price is 155.25

    Share PriceValue
    Today/Current/Last-155.25
    Previous Day-155.15

InsightsLactose (India)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		24.12
    EPS - TTM
    (₹)    		6.44
    MCap
    (₹ Cr.)    		195.44
    Sectoral MCap Rank
    		117
    PB Ratio
    (x)    		4.14
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.40
    3 Months0.83
    6 Months0.44
    1 Year0.60
    3 Years0.58

    		0.40
    VWAP
    (₹)    		156.70
    52W H/L
    (₹)
    200.00 / 56.53

    Lactose (India) Share Price Returns

    1 Day0.06%
    1 Week-5.94%
    1 Month-14.16%
    3 Months11.49%
    1 Year127.71%
    3 Years339.18%
    5 Years473.94%

    ET Stock ScreenersTop Score Companies

    Check whether Lactose (India) belongs to analysts' top-rated companies list?

    View Stock Screeners

    Lactose (India) News & Analysis

    View all Lactose (India) Share News & Announcements

    Lactose (India) Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Lactose (India) Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Lactose (India) Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 72.89% outperformed its 3 year CAGR of 47.7%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent 4.6% of its operating revenues towards interest expenses and 9.34% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income29.6829.7032.8824.6827.75
      Total Income Growth (%)-0.07-9.6633.21-11.056.17
      Total Expenses25.2024.9228.0722.2324.89
      Total Expenses Growth (%)1.12-11.2226.29-10.697.78
      EBIT4.484.784.812.452.86
      EBIT Growth (%)-6.24-0.5695.91-14.17-6.04
      Profit after Tax (PAT)2.272.402.630.810.96
      PAT Growth (%)-5.37-8.74226.27-15.857.54
      EBIT Margin (%)15.1016.1014.629.9410.31
      Net Profit Margin (%)7.658.077.993.263.45
      Basic EPS (₹)1.801.912.090.640.76
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue115.0166.5346.5235.2840.34
      Total Revenue Growth (%)72.8943.0131.87-12.56-1.68
      Total Expenses105.3565.0643.3538.5540.24
      Total Expenses Growth (%)61.9350.0712.47-4.220.72
      Profit after Tax (PAT)6.791.212.45-2.480.07
      PAT Growth (%)461.68-50.69--3,536.20-89.99
      Operating Profit Margin (%)13.0811.3918.026.2214.12
      Net Profit Margin (%)5.961.835.33-7.080.18
      Basic EPS (₹)5.390.962.10-2.400.07

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets100.74101.7890.2288.3483.26
      Total Assets Growth (%)-1.0212.812.136.101.95
      Total Liabilities53.6461.2250.9453.2648.98
      Total Liabilities Growth (%)-12.3820.18-4.368.743.29
      Total Equity47.1040.5639.2835.0934.29
      Total Equity Growth (%)16.123.2611.942.330.12
      Current Ratio (x)1.401.411.531.691.73
      Total Debt to Equity (x)0.810.961.041.201.03
      Contingent Liabilities0.006.593.323.670.55

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 2.24 cr for investing activities which is an YoY increase of 119.95%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities9.428.068.472.177.58
      Net Cash used in Investing Activities-2.24-1.02-0.56-6.18-2.88
      Net Cash flow from Financing Activities-6.23-8.38-8.144.52-3.74
      Net Cash Flow0.95-1.34-0.240.510.96
      Closing Cash & Cash Equivalent1.530.581.922.161.65
      Closing Cash & Cash Equivalent Growth (%)163.34-69.79-11.0431.06139.52
      Total Debt/ CFO (x)4.044.824.8419.384.65

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 14.41% in year ending Mar 31, 2024 outperforming its 5 year avg. of 4.1%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)14.412.976.23-7.060.21
      Return on Capital Employed (%)19.789.9710.992.837.87
      Return on Assets (%)6.731.182.71-2.800.08
      Interest Coverage Ratio (x)3.842.022.510.401.02
      Asset Turnover Ratio (x)1.120.690.5139.5748.09
      Price to Earnings (x)25.9145.8730.86-12.33243.90
      Price to Book (x)3.731.371.920.870.50
      EV/EBITDA (x)10.537.658.9110.685.28
      EBITDA Margin (%)17.6618.5127.9518.6923.87

      No reported Financial Ratios are available.

    Financial InsightsLactose (India)

    • Income (P&L)
    • Cash Flow
    • Ratios

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 72.89% outperformed its 3 year CAGR of 47.7%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent 4.6% of its operating revenues towards interest expenses and 9.34% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 2.24 cr for investing activities which is an YoY increase of 119.95%. (Source: Standalone Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 14.41% in year ending Mar 31, 2024 outperforming its 5 year avg. of 4.1%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Lactose (India) Peer Comparison

    • Lactose (India) Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 338.47% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 338.47% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 338.47% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 338.47% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Lactose (India)24.124.1514.4119.786.7347.7013.085.965.391.400.814.04
          Kimia Biosciences-207.80728.57-1,603.83-6.98-5.31-7.56-2.03-5.06-1.120.88131.122.99
          Bal Pharma31.873.4810.6620.862.3010.667.162.194.941.152.020.42
          Alpa Labs11.941.4911.0413.639.186.5719.3515.428.015.690.031.44
          Aarey Drugs39.261.543.527.101.534.202.451.181.840.580.243.97
          Add More
          Annual Ratios (%)

          Choose from Peers

          • BDH Industries
          • Mangalam Drugs
          • Bafna Pharma
          • Tyche Inds
          • Krebs Biochem

          Choose from Stocks

            See All Parameters

          Peers InsightsLactose (India)

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 338.47% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 338.47% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Lactose (India) Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Lactose (India) Shareholding as on 30 Jun 2024
            Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
            Promoters53.6553.6553.6653.77
            Pledge26.0726.0726.0626.01
            FII0.000.000.000.00
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others46.3546.3546.3446.23
          • Showing Shareholding as on 30 Jun 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters67,53,42653.65 %0.00
            Pledge17,60,57126.07 %0.00
            Others58,35,57446.35 %0.00

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Lactose (India) News Lactose (India) Quarterly Results Lactose (India) Dividend Lactose (India) Q1 ResultsLactose (India) Q2 ResultsLactose (India) Q3 ResultsLactose (India) Q4 Results

          Corporate Actions

          • Lactose (India) Board Meeting/AGM

          • Lactose (India) Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            Aug 12, 2024Aug 06, 2024Board MeetingQuarterly Results
            May 30, 2024May 23, 2024Board MeetingAudited Results
            Feb 14, 2024Feb 05, 2024Board MeetingQuarterly Results
            Nov 02, 2023Oct 23, 2023Board MeetingQuarterly Results
            Sep 07, 2023Aug 16, 2023AGMA.G.M.

          • Dividend announcements are not available.

          • All TypesEx-DateRecord DateAnnounced onDetails
            RightsSep 02, 1994Sep 07, 1994Sep 01, 1994Rights ratio: 3 share for every 5 held at a price of Rs 13.0

          About Lactose (India)

          Lactose (India) Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 195.44 Crore) operating in Pharmaceuticals sector. Lactose (India) Ltd. key Products/Revenue Segments include Pharmaceutical Products, Conversion Charges, Other Operating Revenue and Scrap for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • AM

            Atul Maheshwari

            Managing Director
            SM

            Sangita Maheshwari

            WholeTime Director & CFO
            DJ

            Dhaval Jayant Soni

            Ind. Non-Executive Director
            GK

            G K Sarda

            Ind. Non-Executive Director
            Show More
          • C A S & Co.
            K M Tulsian & Associates

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          Survey No.5,6,7A,Village Poicha (Rania),Savli,Vadodra District, Gujarat - 391780

          Contact

          [email protected]

          http://www.lactoseindialimited.com

          More Details

          FAQs about Lactose (India) share

          • 1. What is Lactose (India) share price and what are the returns for Lactose (India) share?
            As on 29 Aug, 2024, 03:43 PM IST Lactose (India) share price was up by 0.06% basis the previous closing price of Rs 156.4. Lactose (India) share price was Rs 155.25. Return Performance of Lactose (India) Shares:
            • 1 Week: Lactose (India) share price moved down by 5.94%
            • 3 Month: Lactose (India) share price moved up by 11.49%
            • 6 Month: Lactose (India) share price moved up by 3.47%
          • 2. What is the PE & PB ratio of Lactose (India)?
            The PE ratio of Lactose (India) stands at 24.09, while the PB ratio is 4.14.
          • 3. Who owns Lactose (India)?
            Following are the key changes to Lactose (India) shareholding:
            • Promoter holding have gone down from 53.77 (30 Sep 2023) to 53.65 (30 Jun 2024)
            • Other investor holding has gone up from 46.23 (30 Sep 2023) to 46.35 (30 Jun 2024)
          • 4. What is 52 week high/low of Lactose (India) share price?
            52 Week high of Lactose (India) share is Rs 200.00 while 52 week low is Rs 56.53
          • 5. What are the returns for Lactose (India) share?
            Return Performance of Lactose (India) Shares:
            • 1 Week: Lactose (India) share price moved down by 5.94%
            • 3 Month: Lactose (India) share price moved up by 11.49%
            • 6 Month: Lactose (India) share price moved up by 3.47%
          • 6. How can I quickly analyze Lactose (India) stock?
            Key Metrics for Lactose (India) are:
            • PE Ratio of Lactose (India) is 24.12
            • Price/Sales ratio of Lactose (India) is 1.54
            • Price to Book ratio of Lactose (India) is 4.14
          • 7. Which are the key peers to Lactose (India)?
            Within Pharmaceuticals sector Lactose (India), Bafna Pharmaceuticals Ltd., Alpa Laboratories Ltd., Mangalam Drugs and Organics Ltd., Bal Pharma Ltd., BDH Industries Ltd., Tyche Industries Ltd., Krebs Biochemicals & Industries Ltd., Smruthi Organics Ltd., Aarey Drugs & Pharmaceuticals Ltd. and Kimia Biosciences Ltd. are usually compared together by investors for analysis.
          • 8. What are the Lactose (India) quarterly results?
            On Standalone basis, Lactose (India) reported a total income and loss of Rs 29.68 Cr and Rs 2.27 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 115.01 Cr and Rs 6.79 Cr.
          • 9. What is the CAGR of Lactose (India)?
            The CAGR of Lactose (India) is 34.34.
          • 10. What is the market cap of Lactose (India)?
            Within the Pharmaceuticals sector, Lactose (India) stock has a market cap rank of 117. Lactose (India) has a market cap of Rs 195.44 Cr.

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Lactose (India) Share Price
          The Economic Times